project UK
www.hese-project.org/en/
One thing is clear from national and international statistics: there are too many ‘modern diseases’ characterising the western world, and the trends in many diseases are steady and rising. We may be reducing deaths through medical innovation, but this attitude to quality of life is rather like stock car racing: crash and patch: hey it’s fun! ‘Enjoyment’ of modern standards of living is the majority goal, without heed to consequences. And yet research tells us we are not more happy, indeed we are probably more depressed and subject to mental illness. Watching the trends of diseases, and states of health such as obesity appear to be an acceptable return on convenience and consumerism. We have a choice, but only through greater awareness and dialogue will we understand the balance between fulfilled lives and the self-harm of reckless over-consumption.
A record 720 million prescriptions were dispensed last year in the UK, a rise of 50 per cent over the past decade, according to figures released by the NHS Information Centre. Prescriptions for blood pressure and cholesterol-lowering medicines are up to the highest level ever. Prescriptions for blood pressure drugs such as beta-blockers and ACE inhibitors more than quadrupled from 1 million in 1995 to 43 million last year. Cholesterol-reducing drugs went from 2 million prescriptions to 36 million in the same period.
Take with this the following observations:
In fact nitric oxide is possibly the link between cholesterol and blood pressure (a number of research papers show radical oxygen species, cholesterol, NO and eNOS [endothelial nitric oxide synthase] are clearly interlinked).
So what is it about the decade of the mobile phone, cholesterol and blood pressure to lead to such enormous increases in prescriptions? Better medicines? More profligate doctors? Or has the EMF environment something at least to do with it? One counter is that pharmaceutical companies have been pushing particular classes of drugs such as statins, even redefining the boundaries of abnormal blood pressure, but at the same time the UK NHS is under great pressure of costs, and has not encouraged a free-for-all.
© 2009 The h.e.s.e. Project : Human Ecological Social Economic
Source URL: www.hese-project.org/hese-uk/en/issues/disease.php?id=prescriptions06&style=print